Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia

Схожие документы

• Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia
  по: de Benito, Alvaro de Santiago, et al.
  Опубликовано: (2020)
• Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
  по: Bacher, Ulrike, et al.
  Опубликовано: (2018)
• sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
  по: Katja Seipel, et al.
  Опубликовано: (2022-03-01)
• Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series
  по: Flach, Johanna, et al.
  Опубликовано: (2020)
• Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma
  по: Christian Messerli, et al.
  Опубликовано: (2023-08-01)